| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.042 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |